Current Partnerships with NanoDel

MERCK KGaA

Merck KGaA enabled NanoDel Technologies GmbH to start a research program with Merck`s abandoned CNS-compounds in December 2005.

The program focuses on the improvement of the bioavailability of this CNS-compounds, especially the enhancement of the brain uptake using NanoDel`s proprietary nanoparticle carriersystem.

Website: www.merck.de

ESTEVE S.A.

NanoDel Technologies entered a research cooperation with leading Spanish pharmaceutical company Esteve in December 2004. The cooperation focuses on two compounds from Esteve´s pipeline.

The objective of the cooperation is to bind compounds from Esteve´s pipeline to NanoDel´s proprietary Blood-Brain-Barrier-carriersystem and so improve pharmacokinetic and pharmacodynamic properties of Esteve´s drugs. Such improvement offers Esteve a better Life Cycle Management of its drugs.

Website: www.esteve.com